Skip to main content

J. Goldman & Co LP

Position in IMTX — Immatics N.V.

CIK 1412741 NEW YORK, NY

Position in IMTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$224,233
-$15,041 QoQ
Shares Held
22,788
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IMTX Over Time

Shares Held

Position Value (USD)

Derivatives in IMTX

reported options exposure · as of Jun 30, 2025
CallValue
$145,173
CallShares
26,984
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $186,196,918 across 52 Biotechnology names. IMTX ranks #48 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $224,233 22,788
2025-12-31 $239,274 22,788
2025-09-30 $194,153 22,788
2025-06-30 $145,173 26,984
2025-06-30 $122,599 22,788
2025-03-31 $102,773 22,788
2025-03-31 $121,697 26,984
2024-12-31 $162,022 22,788
2024-12-31 $191,856 26,984
2024-09-30 $307,887 26,984
2024-09-30 $260,011 22,788
2024-06-30 $343,231 29,538
2024-06-30 $313,554 26,984
2024-03-31 $283,601 26,984
2024-03-31 $658,262 62,632
2023-09-30 $781,650 67,500
2022-09-30 $269,840 26,984